Shamburg News · 8-K filed Nov 5, 2026, 5:25 PM EST

Annovis Bio Announces Pricing of Approximately $21.0 Million Public Offering

ANVS · Annovis Bio, Inc.

  • Material agreement
  • Financing
  • Reg FD disclosure
  • Materiality: high

On November 5, 2026, Annovis Bio, Inc. entered into an underwriting agreement with Canaccord Genuity LLC for a public offering of 19,000,000 shares of common stock and pre-funded warrants for 2,000,000 shares, with accompanying warrants for up to 21,000,000 shares. The combined offering price per share and accompanying warrant is $1.00, with expected gross proceeds of approximately $21.0 million before discounts and expenses. A director is purchasing 5,000,000 shares and accompanying warrants in the offering, and closing is expected on or about November 6, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 7.01, 9.01, accession 0001104659-26-123467.

Written from the filing by Shamburg Markets. Figures are as reported by the company.